Ai Sato
Tokai University
12 Papers
23 Citations
Ai Sato is an academic researcher from Tokai University. The author has contributed to research in topics: Diffuse large B-cell lymphoma & Lymphoma. The author has an hindex of 5, co-authored 12 publications.
Chat about Author
Papers
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
Ai Sato,Naoya Nakamura,Minoru Kojima,Ken Ohmachi,Joaquim Carreras,Yara Yukie Kikuti,Hiroki Numata,Daisuke Ohgiya,Kei Tazume,Jun Amaki,Makiko Moriuchi,Mitsuki Miyamoto,Yasuyuki Aoyama,Hidetsugu Kawai,Akifumi Ichiki,Ryujiro Hara,Hiroshi Kawada,Yoshiaki Ogawa,Kiyoshi Ando +18 more
TL;DR: The outcome of patients with EBV‐positive DLBCL remains poor, even in the rituximab era, and the median overall survival and progression‐free survival could not be determined inEBV‐negative DLBCl patients.
68
Single nucleotide polymorphisms of cytarabine metabolic genes influence clinical outcome in acute myeloid leukemia patients receiving high-dose cytarabine therapy
Jun Amaki,Makoto Onizuka,Ken Ohmachi,Yasuyuki Aoyama,Ryujiro Hara,Akifumi Ichiki,Hidetsugu Kawai,Ai Sato,Mitsuki Miyamoto,Masako Toyosaki,Shinichiro Machida,Minoru Kojima,Yukari Shirasugi,Hiroshi Kawada,Yoshiaki Ogawa,Kiyoshi Ando +15 more
TL;DR: The results of this study suggest that SNP analysis can be an important tool in improving drug responsiveness and enabling a better understanding of this condition and the development of tailor-made treatments for AML patients who benefit from consolidated high-dose Ara-C therapy.
20
Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report
Minoru Kojima,Daisuke Ogiya,Akifumi Ichiki,Ryujiro Hara,Jun Amaki,Hidetsugu Kawai,Hiroki Numata,Ai Sato,Mitsuki Miyamoto,Rikio Suzuki,Shinichiro Machida,Hiromichi Matsushita,Yoshiaki Ogawa,Hiroshi Kawada,Kiyoshi Ando +14 more
TL;DR: The combination therapy of As2O3 and tamibarotene may be effective and tolerable for treating refractory APL cases who have no treatment options, even when they have previously been treated with tamiborotene and As 2O3 as a single agent.
8
ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation
Mitsuki Miyamoto,Makoto Onizuka,Shinichiro Machida,Masako Toyosaki,Jun Amaki,Yasuyuki Aoyama,Hidetsugu Kawai,Ai Sato,Naoki Hayama,Yoshiaki Ogawa,Hiroshi Kawada,Kiyoshi Ando +11 more
TL;DR: The data support a role for the renin–angiotensin system in the pathogenesis of NIPC after allo-HSCT, and may represent a therapeutic target for complications.
8
Deferasirox treatment improved hematopoiesis and led to complete remission in a patient with pure red cell aplasia.
Minoru Kojima,Shinichiro Machida,Ai Sato,Mitsuki Miyamoto,Makiko Moriuchi,Yoshiaki Ohbayashi,Kiyoshi Ando +6 more
TL;DR: A 64-year-old woman developed pure red cell aplasia (PRCA) 4 years after thymectomy for thymoma and was unable to continue immunosuppressive therapy and became transfusion dependent, but has maintained in complete remission over the last 15 months.
7